全文获取类型
收费全文 | 56653篇 |
免费 | 3421篇 |
国内免费 | 152篇 |
专业分类
耳鼻咽喉 | 488篇 |
儿科学 | 1626篇 |
妇产科学 | 1418篇 |
基础医学 | 8985篇 |
口腔科学 | 621篇 |
临床医学 | 5232篇 |
内科学 | 13315篇 |
皮肤病学 | 1055篇 |
神经病学 | 5193篇 |
特种医学 | 1751篇 |
外国民族医学 | 32篇 |
外科学 | 7456篇 |
综合类 | 315篇 |
一般理论 | 16篇 |
预防医学 | 3878篇 |
眼科学 | 788篇 |
药学 | 3819篇 |
1篇 | |
中国医学 | 120篇 |
肿瘤学 | 4117篇 |
出版年
2023年 | 258篇 |
2022年 | 275篇 |
2021年 | 874篇 |
2020年 | 528篇 |
2019年 | 950篇 |
2018年 | 1468篇 |
2017年 | 994篇 |
2016年 | 1055篇 |
2015年 | 1302篇 |
2014年 | 1519篇 |
2013年 | 2334篇 |
2012年 | 3697篇 |
2011年 | 3753篇 |
2010年 | 2074篇 |
2009年 | 1800篇 |
2008年 | 3507篇 |
2007年 | 3548篇 |
2006年 | 3399篇 |
2005年 | 3520篇 |
2004年 | 3341篇 |
2003年 | 3122篇 |
2002年 | 3087篇 |
2001年 | 1310篇 |
2000年 | 1343篇 |
1999年 | 1163篇 |
1998年 | 507篇 |
1997年 | 428篇 |
1996年 | 366篇 |
1995年 | 357篇 |
1994年 | 314篇 |
1993年 | 298篇 |
1992年 | 710篇 |
1991年 | 612篇 |
1990年 | 588篇 |
1989年 | 554篇 |
1988年 | 494篇 |
1987年 | 482篇 |
1986年 | 451篇 |
1985年 | 397篇 |
1984年 | 325篇 |
1983年 | 261篇 |
1982年 | 192篇 |
1981年 | 172篇 |
1979年 | 215篇 |
1978年 | 148篇 |
1977年 | 141篇 |
1974年 | 157篇 |
1973年 | 147篇 |
1971年 | 147篇 |
1969年 | 158篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Malunguja Gisandu K. Devi Ashalata 《Proceedings of the National Academy of Sciences, India. Section B.》2022,92(1):105-120
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences - Heavy metal concentrations in surface soils of Reserved Forests (RFs) have a significant impact on... 相似文献
3.
Ali Mobasheri Csaba Matta Ilona Uzielienè Emma Budd Pablo Martín-Vasallo Eiva Bernotiene 《Joint, bone, spine : revue du rhumatisme》2019,86(1):29-35
Chondrocytes are the main cells in the extracellular matrix (ECM) of articular cartilage and possess a highly differentiated phenotype that is the hallmark of the unique physiological functions of this specialised load-bearing connective tissue. The plasma membrane of articular chondrocytes contains a rich and diverse complement of membrane proteins, known as the membranome, which defines the cell surface phenotype of the cells. The membranome is a key target of pharmacological agents and is important for chondrocyte function. It includes channels, transporters, enzymes, receptors, and anchors for intracellular, cytoskeletal and ECM proteins and other macromolecular complexes. The chondrocyte channelome is a sub-compartment of the membranome and includes a complete set of ion channels and porins expressed in these cells. Many of these are multi-functional proteins with “moonlighting” roles, serving as channels, receptors and signalling components of larger molecular assemblies. The aim of this review is to summarise our current knowledge of the fundamental aspects of the chondrocyte channelome, discuss its relevance to cartilage biology and highlight its possible role in the pathogenesis of osteoarthritis (OA). Excessive and inappropriate mechanical loads, an inflammatory micro-environment, alternative splicing of channel components or accumulation of basic calcium phosphate crystals can result in an altered chondrocyte channelome impairing its function. Alterations in Ca2+ signalling may lead to defective synthesis of ECM macromolecules and aggravated catabolic responses in chondrocytes, which is an important and relatively unexplored aspect of the complex and poorly understood mechanism of OA development. 相似文献
4.
5.
6.
7.
8.
9.
Dominique Trudel Luminita-Mihaela Avarvarei Michèle Orain Stéphane Turcotte Marie Plante Jean Grégoire Reinhild Kappelhoff David P. Labbé Dimcho Bachvarov Bernard Têtu Christopher M. Overall Isabelle Bairati 《Pathology, research and practice》2019,215(6):152369
Ovarian carcinoma is one of the most lethal malignancies, but only very few prognostic biomarkers are known. The degradome, comprising proteases, protease non-proteolytic homologues and inhibitors, have been involved in the prognosis of many cancer types, including ovarian carcinoma. The prognostic significance of the whole degradome family has not been specifically studied in high-grade serous ovarian cancer. A targeted DNA microarray known as the CLIP-CHIP microarray was used to identify potential prognostic factors in ten high-grade serous ovarian cancer women who had early recurrence (<1.6 years) or late/no recurrence after first line surgery and chemotherapy. In women with early recurrence, we identified seven upregulated genes (TMPRSS4, MASP1/3, SPC18, PSMB1, IGFBP2, CFI – encoding Complement Factor I – and MMP9) and one down-regulated gene (ADAM-10). Using immunohistochemistry, we evaluated the prognostic effect of these 8 candidate genes in an independent cohort of 112 high-grade serous ovarian cancer women. Outcomes were progression, defined according to CA-125 criteria, and death. Multivariate Cox proportional hazard regression models were done to estimate the associations between each protein and each outcome. High ADAM-10 expression (intensity of 2–3) was associated with a lower risk of progression (adjusted hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.29-0.87). High complement factor I expression (intensity 2–3) was associated with a higher risk of progression (adjusted HR: 2.30, 95% CI: 1.17–4.53) and death (adjusted HR: 3.42; 95% CI: 1.72–6.79). Overall, we identified the prognostic value of two proteases, ADAM-10 and complement factor I, for high-grade serous ovarian cancer which could have clinical significance. 相似文献
10.